Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic
  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Junshi Granted US Breakthrough Status for PD-1 in Nasopharyngeal Cancer

Junshi Bio of Shanghai reported the US FDA granted Breakthrough Designation to its PD-1 for nasopharyngeal carcinoma, the first China biopharma awarded BTD for a PD-1 drug. In May of this year, the FDA granted toripalimab orphan drug designation for the same indication. Though relatively rare in the US , NPC is one of the most common malignant tumors in China . In late 2018, toripalimab became the first China-developed PD-1 approved for use in China , where it is marketed as Tuoyi for melanoma patients. More details.... Stock Symbols: (HK: 1877; SHA: 688180) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.